Posts Tagged: "David Jones"

Clause 8 Podcast: HTIA’s David Jones on Winning in Washington

Lucky or that good? David Jones’ time as Executive Director of the High-Tech Inventors Alliance (HTIA), which advocates on patent policy issues on behalf of some of the largest tech companies in the world, suggests that he’s both when it comes to shaping America’s patent system. However, he’s way too modest and strategically wise to take credit or even accept the premise of that question. “I appreciate you saying we’ve had a winning streak. It doesn’t quite feel that way. To me, it feels to me like we’ve kind of clawed our way back to approaching neutral,” Jones says on the latest episode of Clause 8.

How Senate IP Subcommittee Witnesses on Patent Eligibility Responded to Questions from Senator Blumenthal

Through the first half of June, a series of hearings on the state of patent eligibility in America held by the Senate Intellectual Property Subcommittee rendered a variety of interesting exchanges regarding current U.S. subject matter eligibility under Section 101 relating to various important sectors of the U.S. economy. During the second hearing, Senator Richard Blumenthal (D-CT) talked to panelists regarding his concerns about patent abuses in the pharmaceutical industry. During his period of questioning, Blumenthal grilled witnesses on the subject of whether the expansion of subject matter eligibility that would result from the proposed Section 101 draft text would exacerbate issues related to “patent thicketing,” a process by which drug companies attain large patent portfolios covering various aspects of a single drug formulation. Along with Senators Thom Tillis (R-NC) and Mazie Hirono (D-HI), Senator Blumenthal entered a series of questions for the record to be answered by panelists attending the recent patent eligibility hearings. Although the questions don’t overtly single out the pharmaceutical industry, panelist answers largely indicate that this sector was on most people’s mind while responding.

IAM hosts Patent Law and Policy event in Washington, DC

The inaugural IAM event Patent Law & Policy, which will focus on how developments in law and policy affect patent owners’ ability to monetize their rights, will take place in Washington DC on November 17, 2015. This one-day conference in Washington DC offers all those involved in the patent market the perfect opportunity to listen to, learn about and engage in the many legal and policy debates currently taking place around patents.